Timber Creek Capital Management Boosted Qualcomm Com (QCOM) Position; DAINIPPON PHARMACEUT (DNPUF) Shorts Increased By 12.76%

February 20, 2018 - By Marie Mckinney

Timber Creek Capital Management Llc increased Qualcomm Inc Com (QCOM) stake by 33.21% reported in 2017Q3 SEC filing. Timber Creek Capital Management Llc acquired 12,545 shares as Qualcomm Inc Com (QCOM)’s stock rose 2.14%. The Timber Creek Capital Management Llc holds 50,320 shares with $2.61M value, up from 37,775 last quarter. Qualcomm Inc Com now has $91.95B valuation. The stock decreased 4.23% or $2.74 during the last trading session, reaching $62.11. About 7.45 million shares traded. QUALCOMM Incorporated (NASDAQ:QCOM) has risen 9.31% since February 20, 2017 and is uptrending. It has underperformed by 7.39% the S&P500.

DAINIPPON PHARMACEUT (OTCMKTS:DNPUF) had an increase of 12.76% in short interest. DNPUF’s SI was 10.60 million shares in February as released by FINRA. Its up 12.76% from 9.40 million shares previously. It closed at $13.55 lastly. It is down 0.00% since February 20, 2017 and is . It has underperformed by 16.70% the S&P500.

Sumitomo Dainippon Pharma Co., Ltd. makes and sells pharmaceuticals, food ingredients, food additives, veterinary medicines, diagnostics, and others. The company has market cap of $6.13 billion. The firm offers pharmaceutical products, such as therapeutic agents for hypertension, angina pectoris, arrhythmia, ParkinsonÂ’s disease, systemic fungal infections, and hepatocellular carcinoma; atypical antipsychotics; receptor agonists; rapid-acting insulin secretagogues; and biguanide oral hypoglycemic drugs. It has a 11.43 P/E ratio. It also provides products for therapeutic indications, such as Anderson-Fabry disease, antiepileptic, sedative hypnotics, short-acting and long-acting beta-agonist, corticosteroid nasal spray, inhaled corticosteroid, carbapenem antibiotics, gastroprokines, and serotonin-agonist antianxiety drugs.

Since August 28, 2017, it had 0 insider purchases, and 5 insider sales for $2.92 million activity. ROGERS ALEXANDER H had sold 356 shares worth $19,117. GROB MATTHEW S sold $2.81 million worth of stock.

Among 36 analysts covering Qualcomm Inc. (NASDAQ:QCOM), 16 have Buy rating, 1 Sell and 19 Hold. Therefore 44% are positive. Qualcomm Inc. had 133 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Friday, February 12 by Cowen & Co. The stock has “Hold” rating by Topeka Capital Markets on Thursday, November 5. RBC Capital Markets maintained the stock with “Buy” rating in Tuesday, November 14 report. Barclays Capital downgraded QUALCOMM Incorporated (NASDAQ:QCOM) on Monday, March 28 to “Equal-Weight” rating. The firm has “Buy” rating by Mizuho given on Wednesday, January 17. Brean Capital downgraded QUALCOMM Incorporated (NASDAQ:QCOM) on Thursday, June 9 to “Hold” rating. The firm has “Hold” rating given on Wednesday, July 19 by Oppenheimer. On Thursday, July 21 the stock rating was maintained by Mizuho with “Neutral”. Stifel Nicolaus maintained QUALCOMM Incorporated (NASDAQ:QCOM) rating on Thursday, January 26. Stifel Nicolaus has “Buy” rating and $65 target. Canaccord Genuity maintained the shares of QCOM in report on Friday, August 14 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: